| Study Group | Group Comparisonsa | ||||
---|---|---|---|---|---|---|
OA | Gout | RA | OA vs. Gout | OA vs. RA | Gout vs. RA | |
Patient Demographics | Â | Â | ||||
 Number of Patients (n) | 29 | 10 | 8 | - | - | - |
 Sex (M/F) | 5/24 | 7/3 | 4/4 | 0.002 | 0.056 | 0.387 |
 Age (years) | 69 (61–73) | 67 (40–78) | 77 (68–78) | 0.437 | 0.317 | 0.637 |
 BMI (kg/m2) | 27 (25–36) | 28 (25–32) | 28 (22–30) | 0.417 | 0.341 | 1 |
 Disease Duration (years) | 5 (2.5–10) | 8 (6–13) | 10 (5–14) | 1 | 0.274 | 1 |
 Smoker (Past/Current) | 6/2 | 2/1 | 2/1 | 0.662 | 0.873 | 0.924 |
 Standard Drinks (n per week) | 0 (0–2) | 9 (5–40) | 1 (0–4) | 0.017 | 0.535 | 0.029 |
Co-morbidities | ||||||
 Hypertension | 12 | 6 | 3 | 0.567 | 0.074 | 0.057 |
 Diabetes Mellitus | 6 | 0 | 0 | 0.059 | 0.046 | - |
 Hypothyroidism | 4 | 0 | 0 | 0.131 | 0.108 | - |
 Renal Impairment | 3 | 1 | 2 | 0.795 | 0.722 | 0.605 |
 Other Condition/s | 11 | 3 | 2 | 0.409 | 0.144 | 0.577 |
Treatment Regimes | ||||||
 Analgesics | 8 | 6 | 2 | 0.065 | 0.844 | 0.138 |
 Anti-arrhymthmics | 0 | 0 | 1 | - | 0.054 | 0.25 |
 Antibiotics | 2 | 1 | 0 | 0.751 | 0.445 | 0.357 |
 Anti-depressants | 5 | 1 | 0 | 0.66 | 0.207 | 0.331 |
 Anti-hypertensives | 8 | 5 | 3 | 0.195 | 0.587 | 0.596 |
 Anti-inflammatory agents | 6 | 5 | 0 | 0.076 | 0.16 | 0.019 |
 Antiplatelets, Anticoagulants | 4 | 5 | 3 | 0.01 | 0.13 | 0.457 |
 Benzodiazepine | 2 | 1 | 1 | 0.751 | 0.607 | 0.867 |
 Beta-blockers | 2 | 4 | 0 | 0.012 | 0.445 | 0.043 |
 Anti-resorptives, Calcium, Vit D | 3 | 2 | 1 | 0.431 | 0.862 | 0.671 |
 Corticosteroids | 0 | 3 | 4 | 0.002 |  < 0.001 | 0.387 |
 Diuretics | 2 | 2 | 0 | 0.239 | 0.445 | 0.18 |
 DMARDs | 1 | 0 | 5 | 0.552 |  < 0.001 | 0.003 |
 Lipid Lowering Therapy | 4 | 5 | 2 | 0.019 | 0.446 | 0.28 |
 NSAIDs | 6 | 4 | 2 | 0.228 | 0.793 | 0.502 |
 Proton Pump Inhibitors | 5 | 5 | 2 | 0.041 | 0.62 | 0.28 |
 Xanthine Oxidase Inhibitors | 0 | 6 | 0 |  < 0.001 | - | 0.007 |